AI주식인사이트AI Stock Insight
B

이글벳

044960KOSDAQ

60.5 / 100

Reference Date: 2026-10-23

Financial Score29.0 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Revenue metrics are weak. Slightly down 2.9% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Eglvet is a company specializing in the manufacturing and import of animal pharmaceuticals, leveraging the growth of the livestock industry both domestically and internationally. Its key products include nutritional supplements, antibiotics, and vaccines, with active expansion into overseas markets such as Africa, the Middle East, and Southeast Asia. The company is also exploring research opportunities in the growing pet pharmaceutical market.

Number of Employees

110people

Average Salary

48.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
9.68Industry Average 15.006.5Point

Lower than industry avg (good)

PBR
0.74Industry Average 1.205.5Point

Lower than industry avg (good)

ROE
7.85Industry Average 8.002.5Point

Below industry avg

Debt Ratio
6.70Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲0.7% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲13.6% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 7.5% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (14%, downtrend)

Current 3,020Won52-week high 4,50052-week low 2,765
1-month return2.0Point

1m -2.89% (slight drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral[기재정정]반기보고서 (2026.06)2026-10-01